Emma Gibbs
About
Emma Gibbs is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Emma Gibbs has authored 32 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Reproductive Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emma Gibbs's work include Ovarian cancer diagnosis and treatment (9 papers), PARP inhibition in cancer therapy (7 papers) and BRCA gene mutations in cancer (4 papers). Emma Gibbs is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), PARP inhibition in cancer therapy (7 papers) and BRCA gene mutations in cancer (4 papers). Emma Gibbs collaborates with scholars based in Australia, United States and France. Emma Gibbs's co-authors include Val Gebski, Roger Magnusson, Saxon D. Smith, Marjan Khajehei, Valérie Garès, Karen Byth, Chee Khoon Lee, Éric Pujade-Lauraine, Michael Friedländer and James Brown and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and British Journal of Cancer.
In The Last Decade
Emma Gibbs
32 papers receiving 477 citations
Peers
Emma Gibbs
Kate J. Krause United States
Liisa Lyon United States
S. Ackermann Germany
Gregory M. Gressel United States
Jeong Youn Lim United States
Y. Louise Wan Taiwan
Isam Lataifeh Jordan
Teresa Álvarez Spain
Audrey Tieko Tsunoda Brazil
Nawar Latif United States
Citations per year, relative to Emma Gibbs Emma Gibbs (= 1×)
peers
Kate J. Krause
Countries citing papers authored by Emma Gibbs
Since
Specialization
Citations
This map shows the geographic impact of Emma Gibbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Gibbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Gibbs more than expected).
Fields of papers citing papers by Emma Gibbs
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Emma Gibbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Gibbs. The network helps show where Emma Gibbs may publish in the future.
Co-authorship network of co-authors of Emma Gibbs
This figure shows the co-authorship network connecting the top 25 collaborators of Emma Gibbs. A scholar is included among the top collaborators of Emma Gibbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Gibbs. Emma Gibbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Gibbs, Emma, et al.. (2023). (437) Post-Vasectomy Semen Analysis (PVSA) Compliance Rates and Associations. The Journal of Sexual Medicine. 20(Supplement_1).
2.
Lee, Chee Khoon, Clare L. Scott, Geoffrey J. Lindeman, et al.. (2019). Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer. British Journal of Cancer. 120(3). 279–285.
3.
Kirby, Adrienne, et al.. (2019). Risk of preterm birth in the subsequent pregnancy following caesarean section at full cervical dilatation compared with mid‐cavity instrumental delivery. Australian and New Zealand Journal of Obstetrics and Gynaecology. 60(3). 382–388.
4.
Itchins, Malinda, Jennifer Arena, Christopher B. Nahm, et al.. (2018). Pattern of care and survival of pancreatic ductal adenocarcinoma in a multi-disciplinary high-volume centre. Gastroenterology & Hepatology Open Access. 9(5).
5.
Gibbs, Emma, et al.. (2018). Validation of the accuracy of postpartum haemorrhage data in the ObstetriX database: A retrospective cohort study. International Journal of Medical Informatics. 120. 42–49.
6.
Khajehei, Marjan, et al.. (2018). Comparison of the effect of caseload midwifery program and standard midwifery-led care on primiparous birth outcomes: A retrospective cohort matching study. Midwifery. 69. 10–16.
7.
Lindemann, Kristina, Emma Gibbs, Elisabeth Åvall‐Lundqvist, et al.. (2017). Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist). British Journal of Cancer. 116(4). 455–463.
8.
Roncolato, Felicia, Emma Gibbs, Chee Khoon Lee, et al.. (2017). Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy. Annals of Oncology. 28(8). 1849–1855.
9.
Gebski, Val, Emma Gibbs, Mihir Gandhi, et al.. (2017). VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials. JMIR Research Protocols. 6(2). e17–e17.
10.
Bamias, A., Emma Gibbs, Chee Khoon Lee, et al.. (2017). Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial. Annals of Oncology. 28(8). 1842–1848.
11.
Martin, Andrew, Emma Gibbs, Katrin Marie Sjoquist, et al.. (2017). Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma. Gastric Cancer. 21(3). 473–480.
12.
Itchins, Malinda, Jennifer Arena, Christopher B. Nahm, et al.. (2017). Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre. European Journal of Surgical Oncology. 43(9). 1711–1717.
13.
Friedländer, Michael, Val Gebski, Emma Gibbs, et al.. (2017). Health-related quality of life (HRQOL) and patient-centered outcomes with maintenance olaparib compared with placebo following chemotherapy in patients with germline (g) BRCA-mutated (m) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): SOLO2 phase III trial.. Journal of Clinical Oncology. 35(15_suppl). 5507–5507.
14.
Gibbs, Emma, et al.. (2017). Point‐of‐care measurement of fetal blood lactate – Time to trust a new device. Australian and New Zealand Journal of Obstetrics and Gynaecology. 58(1). 72–78.
15.
Lee, Chee Khoon, Clare L. Scott, Emma Gibbs, et al.. (2017). Phase I study of olaparib (O), in combination with oral cyclophosphamide (C), in patients (pts) with metastatic triple negative breast cancer (TNBC) and recurrent high grade serous ovarian cancer (OVCA).. Journal of Clinical Oncology. 35(15_suppl). 1104–1104.
16.
Ledermann, Jonathan A., Alain Lortholary, Richard T. Penson, et al.. (2017). Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2 trial.. Journal of Clinical Oncology. 35(15_suppl). 5518–5518.
17.
Sorio, Roberto, C. Roemer-Bécuwe, Felix Hilpert, et al.. (2016). Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial. Gynecologic Oncology. 144(1). 65–71.
18.
Agar, Meera, Eng‐Siew Koh, Emma Gibbs, et al.. (2015). Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity. Supportive Care in Cancer. 24(3). 1209–1218.
19.
Lee, Chee Khoon, David Goldstein, Emma Gibbs, et al.. (2015). Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib. European Journal of Cancer. 51(7). 852–860.
20.
Bar‐Or, Amit, Joël Oger, Emma Gibbs, et al.. (2009). Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?. Multiple Sclerosis Journal. 15(8). 959–964.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kate J. Krause Breakdown of academic impact, for papers by Liisa Lyon Breakdown of academic impact, for papers by S. Ackermann Breakdown of academic impact, for papers by Gregory M. Gressel Breakdown of academic impact, for papers by Jeong Youn Lim Breakdown of academic impact, for papers by Y. Louise Wan Breakdown of academic impact, for papers by Isam Lataifeh Breakdown of academic impact, for papers by Teresa Álvarez Breakdown of academic impact, for papers by Audrey Tieko Tsunoda Breakdown of academic impact, for papers by Nawar Latif